Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,102,915
-$273,322 QoQ
Shares Held
8,583
-25.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#2,036
of 3,769 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tyche Wealth Partners LLC holds $18,163,637 across 7 Drug Manufacturers - General names. MRK ranks #4 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,399 | $5,688,674 | |
| 2 | LLY |
ELI LILLY & Co
|
4,653 | $5,580,948 | |
| 3 | ABBV |
AbbVie Inc.
|
17,400 | $4,378,536 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
8,583 | $1,102,915 | |
| 5 | AMGN |
Amgen Inc
|
1,495 | $541,369 | |
| 6 | PFE |
Pfizer Inc
|
21,503 | $517,792 | |
| 7 | NVS |
Novartis AG
|
2,255 | $353,403 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,102,915 | 8,583 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,376,237 | 11,441 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,535,006 | 14,583 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $674,293 | 8,034 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $644,283 | 8,139 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $875,788 | 9,757 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,268,966 | 12,756 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $881,793 | 7,765 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $969,725 | 7,833 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $1,245,871 | 9,442 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $1,435,575 | 13,168 | Shares | Sole | 2024-01-30 | |
| No filing history on record for this holder in this stock. | ||||||